Posted Mar. 23, 2011 at 12:18 p.m.
Chapel Hill, N.C. —
Pozen licenses migraine drug to J&J subsidiary
Post a comment
Print this blog postE-mail blog post
Share
Chapel Hill, N.C. —
Cilag GmbH International gained rights to MT 400 for Brazil, Columbia, Ecuador and Peru. Cilag is responsible for the manufacturing, development and commercialization of MT 400 in those countries.
Pozen will receive an upfront payment of an undisclosed amount.
GlaxoSmithKline (NYSE: GSK) licenses the drug in a different dosage for sale in the US under the name Treximet.
Get the latest news alerts: Follow WRAL Tech Wire at Twitter.
...Copyright 2013 WRAL Tech Wire. All rights reserved.
Please log in to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too- ArchiveSocial, a new Durham success story, brings home international award
- Durham's high-tech infrastructure, talent lure Virginia company
- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows